Julie Rubinstein - Mar 4, 2024 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
President
Signature
/s/ Julie Rubinstein by Stacy L Taylor, Attorney-in-Fact
Stock symbol
ADPT
Transactions as of
Mar 4, 2024
Transactions value $
-$135,764
Form type
4
Date filed
3/6/2024, 07:41 PM
Previous filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Award $0 +175K +51.96% $0.00 512K Mar 4, 2024 Direct
transaction ADPT Common Stock Sale -$87.7K -25.6K -5% $3.43 486K Mar 5, 2024 Direct F1
transaction ADPT Common Stock Sale -$48K -13.5K -2.77% $3.56 473K Mar 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.